Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 2Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1Head and Neck Neoplasms 1

Interventions

plerixafor 1pazopanib 1lorukafusp alfa 1liposomal doxorubicin 1imetelstat 1Temozolomide 1Pentetic Acid 1Palliative Care 1Nutritional Support 1Minocycline 1MAGEA3 protein, human 1MAGEA1 protein, human 1Heparin 1Glutamine 1Gemcitabine 1GRN163L peptide 1Filgrastim 1Erlotinib Hydrochloride 1Electroacupuncture 1Docetaxel 1Dexamethasone 1Celecoxib 1Calcium Carbonate 1Analgesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Osteosarcoma × plerixafor × Clear all
NCT03612466 2022-10-14

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Albert Einstein College of Medicine

Phase 1 Withdrawn
Sarcoma

Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡